Daxor Announces University of California, San Diego Medical Center Acquires Blood Volume Analyzer BVA-100.NEW YORK -- Daxor Corporation (AMEX AMEX See: American Stock Exchange :DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the University of California, San Diego UCSD is consistently ranked among the top ten public universities for undergraduate education in the United States by U.S. News & World Report.[3] It is a Public Ivy. [1] For graduate studies, most of UCSD's Ph.D. (UCSD UCSD University of California, San Diego (La Jolla, California) UCSD User Centered System Design UCSD Urbana-Champaign Sanitary District (Illinois) UCSD Ultra Cool Sexy Dudes ) Medical Center at Hillcrest. Dr. David Hoyt, UCSD Medical Center's Chief of the Division of Trauma, Burn and Surgical Intensive Care, stated that, "Daxor's revolutionary instrument which provides blood volume measurements will be a vital addition in the critical care setting where understanding a patient's blood volume status is essential." Dr. Hoyt, the Past Chairman of the American College of Surgeons This article or section needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Committee on Trauma and the Past President of the Society of General Surgeons, remarked that, "We intend to utilize the BVA-100 in our clinical evaluation of patients to more accurately determine our course of treatment as it relates to fluid management and blood transfusions." Dr. Barry Greenberg, Director of the Advanced Heart Failure Program, said that, "The ability to accurately assess and measure blood volume should be a substantial aid to us in managing our heart failure patients and, in particular, adjusting their diuretic dose. It should give us another parameter to assess in deciding when a patient may be ready for discharge from the hospital." UCSD Medical Center The UCSD Medical Center is a major research hospital located in the Hillcrest neighborhood of San Diego, California. Along with the UCSD Thornton Hospital in La Jolla, it is the primary teaching center of the UC San Diego School of Medicine, and School of Pharmacy. is the clinical system operated by the University of California, San Diego, part of the renowned University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). system. As the only university-based health care system in the region, UCSD Medical Center is the primary site for such regional services as the comprehensive organ transplant program offering heart, lung, kidney, pancreas, liver and bone marrow transplantation Bone Marrow Transplantation Definition The bone marrow—the sponge-like tissue found in the center of certain bones—contains stem cells that are the precursors of white blood cells, red blood cells, and platelets. ; the Regional Burn Center; the National Institutes of Health-designated Clinical Research Center; the Infant Special Care Center; the region's only National Cancer Institute designated Comprehensive Cancer Center; and the county's only Level I Trauma Center In the United States, a Level I trauma center provides the highest level of surgical care to trauma patients. A Level I trauma center is required to have a certain number of surgeons and anesthesiologists on duty 24 hours a day at the hospital, an education program, . Dr. Carl Hoh, the Division Chief and Associate Professor of Radiology said, "We are acquiring the BVA-100 because of its efficient and accurate way of measuring plasma volumes for use in patient management. Our hope is that the BVA-100 will make blood volume testing a more routine parameter of clinical management in such areas as heart failure, trauma, hemodialysis, etc." Contact Information: Daxor Corporation Stephen Feldschuh, 212-330-8515 (VP of Operations) stephen@daxor.com or Diane Meegan, 212-330-8512 (Investor Relations) dmeegan@daxor.com. Additional information can be found at www.Daxor.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion